Recurrent gestational trophoblastic disease following in-vitro fertilization.

Abstract

Recurrence of gestational trophoblastic disease (GTD) following two attempts at in-vitro fertilization (IVF)/embryo transfer is reported in a childless couple after 17 years of unsuccessful trials of ovulation induction. The diagnosis of bilateral tubal obstruction was finally established, indicating IVF treatment. After the first IVF/embryo transfer treatment, the woman developed GTD and was treated with methotrexate. After a second IVF attempt, GTD was again diagnosed. This time there was no response to methotrexate, thus necessitating second-line chemotherapy. Etoposide, methotrexate, actinomycin D, cyclophosphamide, oncovine was used, and after only four treatment cycles the beta-human chorionic gonadotrophin (HCG) dropped to < 5 mIU/ml. After 26 months of follow-up, the beta-HCG continues to be undetectable. Preimplantation evaluation and ovum donation are described as measures to minimize the risk for GTD recurrence in a future IVF/embryo transfer.

Statistics

05001000'04'05'06'07'08'09'10'11'12'13'14'15'16'17
Citations per Year

704 Citations

Semantic Scholar estimates that this publication has 704 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Tanos1994RecurrentGT, title={Recurrent gestational trophoblastic disease following in-vitro fertilization.}, author={Vasilios Tanos and Dror Meirow and Benjamin E. Reubinoff and Shaul O. Anteby}, journal={Human reproduction}, year={1994}, volume={9 11}, pages={2010-3} }